StockPriceToday
Ares Capital Corporation (ARCC)
About Ares Capital Corporation
Ares Capital Corporation operates as a leading business development company (BDC) providing financing solutions to middle-market companies across various industries. The company's lending focus makes ARCC stock price sensitive to interest rate changes, credit market conditions, and middle-market business performance.
The company provides debt and equity financing to established middle-market businesses that typically have annual revenues between $10 million and $2.5 billion. Ares Capital's portfolio includes senior secured loans, subordinated debt, and equity investments that generate interest income and capital appreciation.
ARCC stock price benefits from the company's diversified portfolio, experienced investment management team, and focus on generating consistent dividend income for shareholders. The company's investment approach emphasizes downside protection while seeking attractive risk-adjusted returns.
Ares Capital's substantial assets under management and established market presence position the company to capitalize on middle-market financing opportunities. The company's dividend yield and portfolio quality support ARCC stock price attractiveness for income-focused investors seeking exposure to private credit markets and middle-market business financing.
ARCC Stock 12 Month Chart
Latest News for ARCC
View Ares Capital Corporation ARCC stock quote prices, financial information, real-time forecasts, and company news from CNN.
NEW YORK, NY / ACCESS Newswire / April 1, 2026 / Ares Capital Corporation ("Ares Capital") (NASDAQ:ARCC) announced today that it will report earnings for the first quarter ended March 31, 2026 on ...
Ares Capital (ARCC) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Other Popular Stocks
Bank7 Corp. operates as a bank holding company providing commercial and retail banking services primarily in Oklahoma and Kansas.
Arbutus Biopharma Corporation is a biotechnology company focused on developing therapies for chronic hepatitis B virus infection.
Vivid Seats Inc. (SEATW) warrants provide the right to purchase SEAT common stock at a predetermined price, offering leveraged exposure to the online ticket...